Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Multiple Myeloma × Aprepitant × Clear all

Phase

Status

Completed 5 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 8 Nausea 5 Neoplasms 2 Lymphoma 2 Squamous Cell Carcinoma of Head and Neck 1 Radiation Injuries 1 Postoperative Nausea and Vomiting 1 Post-Dural Puncture Headache 1 Multiple Myeloma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hematologic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Dexamethasone 52 Cyclophosphamide 35 Bortezomib 27 Melphalan 21 Lenalidomide 17 pomalidomide 14 Thalidomide 14 fludarabine 10 daratumumab 8 carfilzomib 7 Filgrastim 7 Doxorubicin 6 Busulfan 6 Prednisone 5 Peripheral Blood Stem Cell Transplantation 5 fludarabine phosphate 4 Surveys and Questionnaires 4 Mycophenolic Acid 4 Clarithromycin 4 Calcium Dobesilate 4 Bendamustine Hydrochloride 4 selinexor 3 sargramostim 3 liposomal doxorubicin 3 ixazomib 3 isatuximab 3 Radiotherapy 3 Neoadjuvant Therapy 3 Methylprednisolone 3 Interferon-alpha 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00571168 2010-01-12

EmNa

Heidelberg University

Phase 3 Unknown

Multiple Myeloma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡